Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
Edmonson
J H
JH
Long
H J
HJ
Jeffries
J A
JA
Buckner
J C
JC
Colon-Otero
G
G
Fitch
T R
TR
D000970:Antineoplastic Agents / Q000009:adverse effects; D016190:Carboplatin; D003115:Colony-Stimulating Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006098:Granulocytes; D006133:Growth Substances / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008264:Macrophages; D009944:Organoplatinum Compounds / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control*
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D009944:Organoplatinum Compounds; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016190:Carboplatin